In the organization quality systems are well defined processes. Any aberration is mapped against the correct process to check for non compliance. If processes are inadequate, they are rejiggered and standards are reset. Gap Analysis, taking into accounts both internal & external context of competitive environment, forms the basis of strategizing for the future. Business excellence is achieved through leadership in Customer focus & satisfaction , Strategic Planning, Process Management & Information Analysis. Excesses This has always been a beckon light paradigm for the company .
 
The company today is aiming at 200 million sales in current financial year and in the coming two years. time to achieve 500 million sales , with its operations spread all over the country with 250 people in the field which will increase to 400 by 2006. with a well researched portfolio of . high yield. and . high potential. products that are in growth phase in the industry. Today the company is into the therapeutic segments of Surgery, Neurology, Gynaecology, Medicine, Dental, & ENT, with anti-inflammatory antibiotics, hormone, anti-anemic and neuro tonics.
 
Emphasis is on high investment in field force training and marketing programmers with the objectives of building brands and creating strong presence in the market.
 
The organization helps employees to understand that they have to contribute and helps them do that. Emphasis on personal growth and development is a way to influence employee motivation, not only to maximize their contribution but also thereby to improve the productivity of the company.
 
Manpower being the greatest asset of the company, is treasured the most. They all are cultured into a role of family member of OBSURGE FAMILY. A high degree of involvement of all members has made OBSURGE a force to reckon with. As a part of ambitious growth plan the management is envisaging new divisions in near future to service the specialty segment of Cardiology, Drabetology and Oncology. Shortly, Company's presence in international market will be noticed especially in South East Asia, North West & Central Africa.
 
A collaboration with a phrama major player from Europe is in advance stage which will help company to service the medical fraternity with novel delivery systems for the molecules and also make available products to fill up therapy gaps.